Journal of the European Academy of Dermatology and Venereology
Expert consensus recommendations synthesizing RCT and real-world evidence on malignancy risk with biologic and oral targeted therapies in psoriasis and atopic dermatitis, addressing a clinically important gap in populations excluded from trials.